SXSW 2025

Ketamine Is Here to Stay

Description:

Despite decades of evidence supporting ketamine's efficacy and safety for treating conditions such as suicidality, depression, and anxiety, the lack of regulation, standardization, and best practices for Ketamine-Assisted Psychotherapy (KAP) has led to widespread confusion. This panel will explore these issues and propose pathways for ketamine to achieve FDA approval and insurance coverage, ensuring its place as a reliable option in the mental health treatment toolkit.

Related Media

Youtube Video

Takeaways

  1. Why ketamine is so important to our current mental health crisis.
  2. The current state of Ketamine-Assisted Psychotherapy as an industry.
  3. How we can move toward FDA approval and insurance coverage for Ketamine-Assisted Psychotherapy.

Speakers

Organizer

Kevin Cannella, Executive Director, Thank You Life

Meta Information:

  • Event: SXSW
  • Format: Panel
  • Track: Psychedelics
  • Track 2
  • Level: Advanced
Show me another idea

Add Comments

SXSW reserves the right to restrict access to or availability of comments related to PanelPicker proposals that it considers objectionable.